RxDoctor Payments Data

Thomas Blackledge, MD

Family Medicine · Magee, MSNPI 1497798615

Payments from drug & device makers

$393in general payments, 2019–2025

Across 24 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$180
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$40
  • Novo Nordisk$34
  • Amgen$31
  • Pfizer$26
  • AstraZeneca$23
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$393 in reported general payments places this provider in the 40th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$8,943
Medicare patients
184
Services billed
577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban45$40,616
OzempicSemaglutide30$33,225
JardianceEmpagliflozin29$32,003
LinzessLinaclotide37$28,944
TrulicityDulaglutide19$18,153
XareltoRivaroxaban15$13,375
Atrovent HfaIpratropium Bromide27$12,931
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,974
FarxigaDapagliflozin Propanediol15$8,413
Combivent RespimatIpratropium/Albuterol Sulfate12$6,586
SymbicortBudesonide/Formoterol Fumarate22$5,467
Gabapentin153$3,066
Sucralfate78$2,956
Losartan Potassium384$2,932
Quetiapine Fumarate187$2,742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$26$40,61645 claims
Boehringer IngelheimJardiance, Combivent Respimat$15$38,58941 claims
Novo NordiskOzempic$34$33,22530 claims
AbbVieLinzess$180$28,94437 claims
AstraZenecaFarxiga, Symbicort$23$13,88037 claims
GSKTrelegy Ellipta$14$10,97414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Magee

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →